Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank45
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P45
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
145.09%
Historical baseline
PeriodValue
20250.00%
202411.47%
2023-18.24%
2022-48.11%
2021-350.85%
202051.65%
2019-68.54%
20186.16%
2017-280.77%
20162148.16%